Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
Chen
K K
KK
Chang
L S
LS
Chen
M T
MT
Huang
J K
JK
Yin
J H
JH
Lin
S N
SN
Lin
A D
AD
D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D008875:Middle Aged; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology; D014554:Urination / Q000187:drug effects; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology; D014563:Urodynamics / Q000187:drug effects*
D010643:Phenoxybenzamine